T. Mary Thistle's most recent trade in Entrada Therapeutics Inc was a trade of 19,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Entrada Therapeutics Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Vigil Neuroscience Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 5,000 | 5,000 | - | 0 | Common Stock | |
| Q32 Bio Inc. | T. Mary Thistle | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Feb 2025 | 12,767 | 0 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Mary Thistle T. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 12,767 | 12,767 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vigil Neuroscience Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 18,068 | 18,068 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Mary T. Thistle | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 May 2024 | 24,309 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 24,309 | 24,309 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Mary T. Thistle | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 May 2024 | 13,928 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 13,928 | 13,928 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Mary T. Thistle | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 May 2024 | 12,155 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 12,155 | 12,155 | - | - | Stock Option Award (Right to Buy) | |
| Q32 Bio Inc. | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 12,767 | 12,767 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 23,000 | 23,000 | - | - | Option (Right to Buy) | |
| Entrada Therapeutics Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vigil Neuroscience Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 13,928 | 13,928 | - | - | Stock Option Grant (Right to Buy) | |
| Alaunos Therapeutics Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 45,000 (0%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 45,000 (0%) | 0% | 0 | Common Stock | |
| Q32 Bio Inc. | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 18,000 | 18,000 | - | - | Option (Right to Buy) | |
| Vigil Neuroscience Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 12,155 | 12,155 | - | - | Stock Option Grant (Right to Buy) | |
| Entrada Therapeutics Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 11,918 | 11,918 | - | - | Stock Option (Right to Buy) | |
| Vigil Neuroscience Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2022 | 24,309 | 24,309 | - | - | Stock Option Grant (Right to Buy) | |
| Entrada Therapeutics Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 11,918 | 11,918 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 18,000 | 18,000 | - | - | Option (Right to Buy) | |
| Alaunos Therapeutics Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 37,500 | 37,500 | - | - | Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Mary T. Thistle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 5,000 | 5,000 (0%) | 0% | 0 | Common Stock |